The Cambridge Independent Business Awards 2025 are now open for entry. Following the success of our inaugural awards last year, we are delighted to announce that the search is now on for the best in ...

Frontier IP announced on Friday that it has entered into a strategic partnership with property developer Abstract Mid-Tech to ...

How are contractors meeting the challenges of designing life sciences buildings that are fit for the future? In south London, ...

Sotheby’s has finally revealed what its plans are for Breuer’s building. Today, the international auction house, alongside the Pritzker prize-winning architecture firm Herzog & de Meuron, unveiled ...

AstraZeneca's plan to invest £450 million ... After Reeves came into office she carried out an audit of public spending, claiming that she had inherited a £22 billion “black hole” in ...

Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built with exactly ...

AstraZeneca announced a strategic research collaboration with CSPC Pharmaceuticals to advance AI-enabled drug discovery. This partnership aims to develop novel o ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and biotech firm based in Cambridge, UK, reported positive results from its Phase 3b Batura trial. The study found that Airsupra, its dual-action ...